BEIJING CC-PHARMING
Beijing CC-Pharming is a company specializing in biomedical technology research and product development. High-tech innovative enterprises. Based on plant bioreactor technology, the company is committed to "make affordable bio medicines for the common people", and researches and develops a variety of biomedicine and recombinant protein products.The company has independently developed the core patent technology-"Plant Transient Protein Expression Technology". Using this technology, the company can... use the plant system to express highly within 4 days and purify the medicinal protein in 3 days (up to 1.6 grams of medicinal protein per kg of lettuce). This technology has greatly reduced the cost of biopharmaceutical production, improved the efficiency and safety of drug production, and provided a new way of production for biopharmaceuticals. It has a clear advantage in global competition in the same industry and will provide society with "green, safe, Efficient and economical biomedical products.
BEIJING CC-PHARMING
Industry:
Biotechnology Clinical Trials Health Care
Founded:
2017-01-01
Address:
Beijing, Beijing, China
Country:
China
Website Url:
http://www.cc-pharming.com
Status:
Active
Contact:
(010) 5972 5617/(010)5972 5618
Technology used in webpage:
HiChina DNS
Similar Organizations
Gynica
Gynica is a research and development company specializing in therapeutic cannabis research in the field of women's health.
NeuPharma
NeuPharma is a biotech company dedicated to research and development of innovative medicines.
POC Clinical Research
POC Clinical Research is a company specializing in R & D support for advanced medical technology, and provides development strategies.
Trial Informatics
Trial Informatics is a data science company that specializes in clinical trial data with digital health technologies.
Official Site Inspections
http://www.cc-pharming.com Semrush global rank: 10.56 M Semrush visits lastest month: 221
Unable to get host informations!!!
More informations about "Beijing CC-Pharming"
Beijing CC-Pharming - Crunchbase Company Profile
Beijing CC-Pharming is a company specializing in biomedical technology research and product development. High-tech innovative enterprises. Based on plant bioreactor technology, the company is committed to "make affordable bio …See details»
CC-Pharming | VentureRadar
CC-Pharming is located in Zhongguancun Biomedical Engineering Transformation Center, Shunyi District, Beijing, China. The company is specialized in plant molecular medicine technology …See details»
Beijing CC-Pharming Ltd. (睿诚海汇生物科技（山东）有限公司)
了解Beijing CC-Pharming Ltd. (睿诚海汇生物科技（山东）有限公司)公司的药物管线，治疗领域，技术平台，以及它的。See details»
Beijing CC-Pharming Ltd. - Drug pipelines, Patents, Clinical trials ...
Last update 19 Sep 2024. Beijing CC-Pharming Ltd. Private Company |See details»
CC-Pharming Company Profile - Office Locations, Competitors
CC-Pharming Summary. Company Summary. Overview. Beijing CC-Pharming (北京睿诚海汇健康科技) is a company specializing in biomedical technology research and product …See details»
CC-Pharming - Products, Competitors, Financials, Employees ...
Feb 3, 2020 iBio and CC-Pharming Initiate Joint Development of Coronavirus Vaccine. Feb 3, 2020. 01/31 01/16 0 Message : *Required fields NEW YORK, Feb. 03, 2020 (GLOBE …See details»
Cc-Pharming - Biotech Careers
Cc-Pharming is a cpmany specializing in biomedical technology research and product development, using plant bioreactor technology. Business Areas: COVID-19, VaccinesSee details»
Beijing CC-Pharming Ltd. - CMOCRO - Domain Name
Beijing CC-Pharming is specialized in plant molecular medicine technology research and product development using proprietary tobacco and lettuce transient expression platforms, focusing on …See details»
Nextsource | Company Profile | Beijing CC-Pharming
Find out if Beijing CC-Pharming is undergoing leadership changes or executive team restructuring. Learn about mergers or acquisitions involving Beijing CC-Pharming . See how …See details»
iBio Establishes Strategic Commercial Relationship with
Jul 9, 2018 CC-Pharming is an excellent partner for iBio due to the depth of its expertise and the vision we share for bringing significant product benefits of iBio’s technology and capabilities, …See details»
Beijing CC-Pharming Ltd. - BioCentury Company Profiles - BCIQ
Beijing CC-Pharming Ltd. - BioCentury Company Profiles for the biopharma industrySee details»
iBio and CC-Pharming Expand Business Collaboration in China
Aug 26, 2019 CC-Pharming is located in Zhongguancun Biomedical Engineering Transformation Center, Shunyi District, Beijing, China. The company is specialized in plant molecular …See details»
Companies work to bring antibody drug to China
Dec 2, 2024 CC-Pharming is paying iBio $4.7 million to be its China partner for joint development of products and manufacturing facilities for the Chinese biopharmaceutical …See details»
Bryan-based iBio announces Chinese partnership - KBTX News 3
Oct 2, 2018 According to a press release, CC-Pharming will manage all operations from China with iBio being a joint owner in the business. The two companies are planning an …See details»
iBio Establishes Strategic Commercial Relationship with CC …
Rituximab has been placed on the World Health Organization’s List of Essential Medicines, but despite the development and approval of biosimilar versions, it is still too expensive for many …See details»
iBio and CC-Pharming Hold First Design and Strategy Meeting
Oct 2, 2018 CC-Pharming and iBio expect to jointly select additional products for development and joint exclusive sales in China using iBio’s proprietary plant-based approach. As …See details»
Current updates and research on plant-based vaccines for …
If the vaccine has been successfully developed, CC-Pharming has agreed to aid iBio in testing the vaccine in China . At the moment this article is written there are no information regarding the …See details»
CC-Pharming - VentureRadar
"CC-Pharming is located in Zhongguancun Biomedical Engineering Transformation Center, Shunyi District, Beijing, China. The company is specialized in plant molecular medicine …See details»
iBio and CC-Pharming collaborate for rituximab copy biological in …
The commercial licence allows CC-Pharming to use iBio’s FastPharming System to develop iBio Rituximab, and fulfils the companies’ intention to share revenue from CC-Pharming’s sale of …See details»
iBio looks to exit CDMO business, cut staffing levels by 60%
Nov 8, 2022 Offloading its contract development and manufacturing organization (CDMO) assets will enable it to fully ... iBio grants CC-Pharming exclusive license to commercialize rituximab …See details»